Conversations on Today’s Priorities!
Thought-provoking, worldwide issues will be deconstructed by acclaimed panelists representing multiple stakeholders from around the world in this growing ecosystem of life sciences. DIAmonds represent rare opportunities to listen to open conversations on controversial topics such as owning health data, innovation in global health, and international regulatory collaboration.
EU Regulatory Townhall
Join a conversation with EMA and European Commission representatives on the promises and challenges of a new EU Pharma Legislation. Discuss the progress and important steps towards a sustainable implementation of the new legislation.
Turning Europe’s Framework into a Competitive Advantage
Europe is reshaping its healthcare ecosystem through the EU pharmaceutical reform, Biotech Act, IVDR/MDR changes, AI Act, European Health Data Space, HTA Regulation and more. One year after DIA Europe 2026 set out ambitious plans for regulatory transformation, this session asks how much progress has been made, how fast Europe is moving, and whether these building blocks are connecting into one coherent innovation ecosystem.
Patients as Partners in Development: Shift in the Balance of Knowledge
This session explores how patient engagement can become true co-creation, with patients partnering from the earliest stages and helping to shape development priorities, study design, meaningful outcomes and evidence generation. Drawing on EMA experience, it shows how robust, fit-for-purpose methods turn patient experience into evidence, and why trust, transparency, capacity and early dialogue are the conditions that make co-creation work.
Europe’s Digital Regulation Moves from AI Strategy to Real Impact
The EMA Network is moving from AI strategy to implementation. This session showcases activities under the NDSG AI Roadmap and the New Pharmaceutical Legislation, including Knowledge Mining, AI assistants and Scientific Explorer, and shows how collaboration across regulators, industry, academia and patients keeps AI-driven transformation trustworthy and focused on public health outcomes.
Women’s Health
Momentum on women’s health is building across Europe and globally. This session presents where EMA and the European Medicines Regulatory Network stand, and hears from patients, clinicians, academia, NGOs and industry on how we can work together to advance women’s health.